Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis.

Gut Liver · 2022 · PMC8761915 · PMID 34140428

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

showed a trendp=0.055so close (0.05 < p ≤ 0.1)

Compared with upfront surgery, neoadjuvant therapy showed a trend towards prolonged PFS in matched groups (p=0.055), but not in OS (p=0.81).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.